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Summary: Conformational changes of hexo- of these are induced by glucose and glucose
kinase from ascites tumor cells have been studied 6-phosphate, respectively,
by chemical modification of lysine residues with
 3) Treatment of membrane-bound enzyme
imidoesters with the foUowmg results: ^ ^ ^ suberimidate affects its sensitiv-
1) The membrane-bound enzyme, in contrast to ^to fte !nhlbitio!1 * ^ f™ 6^^e.·but
the soluble enzyme, is not inactivated by treat- "°l lts ^ vrty or degree of maxinud inhibition,
ment with dimethyl suberimidate, which suggests ^s suggests that lysme(s) is related to the
(a) lysine residue(s) essential for the activitythat bm^ of glucose 6-phosphate to its aUostenc
is protected in the membrane-bound enzyme. re^u a or^ S1 e'
4) In intact tumor cells, most, if not all, of the
2) Three different conformations have been hexokinase activity seems to be in a membrane-
detected in the membrane-bound enzyme. Two bound form.
Mitochondriale, membrangebundene Hexokinase aus Ascites-Tumorzellen. Untersuchungen zur
fiinktionellen Bedeutung von Lysin-Resten durch Modifikation mit Imidoestern
Zusammenfassung: Konformationsänderungen deutet auf (einen) Lysin-Rest(e) hin, die essen-
der Hexokinase aus Ascites-Tumorzellen wurde tiell sind für die Aktivität und beim membran-
mit Hilfe chemischer Modifikationen der Lysin- gebundenen Enzym geschützt vorliegen.
Reste durch Imidoester untersucht. Die Ergeb-
 2) Für das membrangebundene Enzym wurden
msse waren folgende: ^
 verschiedene Konformationen gefunden,
l) Das membrangebundene Enzym wird im Ge- Zwei von ihnen werden durch Glucose bzw.
gensatz zum löslichen Enzym nicht durch Behand- Glucose-6-phosphat induziert.
lung mit Dimethylsuberimidat inaktiviert. Das
Enzymes:
Hexokinase, ATP:D-hexose 6-phosphotransferase (EC 2.7.1.1);
Lactate dehydrogenase, lactate:NAD® oxidoreductase (EC 1.1.1.27);
Pyruvate kinase, ATP:pyruvate 2-0-phosphotransferase (EC 2.7.1.40).
Abbreviations:
Sbi(OMe)2 = Dimethyl suberimidate dihydrochloride;
Tes = 2-{[2-hydroxy-l,l-bis(hydroxymethyl)ethyl]amino}ethanesulphonic acid; for Reagents 2-5 see "Materials".
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3) Behandlung des membrangebundenen Enzyms
mit Dimethylsuberimidate beeinflußt seine Emp-
findlichkeit gegenüber einer Hemmung mit
Glucose-6-phosphat, aber nicht seine Aktivität
und nicht seine maximale Hemmbarkeit. Das läßt
vermuten, daß eine Beziehung besteht zwischen
(einem) Lysin-Rest(en) und der Bindung von
Glucose-6-phosphat an dessen allosterischen Re-
gulationsort.
4) In intakten Tumorzellen scheint die meiste,
wenn nicht die gesamte Hexokinase-Aktivität in
membrangebundener Form vorzuliegen.
Key words: Hexokinase; lysine residues; conformational changes; ambiquitous enzymes; tumor.
It is well established that proteins, when bind-
ing a ligand, are able to undergo a conformational
change. Such changes have been identified in
yeast hexokinase by functional I1! and structural
studies!21. In mammals, the most studied hexo-
kinase is isoenzyme I from brain, reviewed by
Wilson!3!, which exists in a soluble and particulate
formt4'5!. The enzymes that can be found in these
two forms have been called ambiquitous en-
zymes!3!. Conformational changes in a soluble
purified preparation of the brain isoenzyme have
been determined by the study of kinetic para-
meters after several kinds of treatment: using
proteolytic enzymes!6·7!, physical agents!6·7!,
and group-specific reagents!6"8!. As a result, a
functional model of the enzyme has been
proposed!3'6!.
In this report we have studied the possibility of
the existence of such conformational changes in
the isoenzyme II of animal hexokinase from
ascites tumor cells, which also exists in a soluble
and mitochondria! membrane-bound form!9!. The
change from one form to the other can have an
effect on its kinetic properties!1 °1. This isoenzyme
is consequently an ambiquitous enzyme, though
its physiological significance has not yet been
established. Almost nothing is known about its
primary structure, subunit composition and
three-dimensional structure. Only recently some
studies have been performed regarding the nature
of its active site!11·12!. We have treated this
isoenzyme with different kinds of monofunction-
al and bifunctional imidoestersl13! in the pres-
ence of different ligands, in order to catch dif-
ferent conformations of the enzyme in a stable
form. Kinetic parameters were used as markers
of such possible conformational changes. For
these studies we have used mitochondrial mem-
branes, since no in vitro reconstitution system
for the particulate enzyme has yet been developed.
The results reported here have improved our
understanding of the role played by different
lysine groups in different aspects of enzyme
function: binding to mitochondrial membrane,
conformational changes and catalytic and reg-
ulatory processes. Nevertheless the specific
identification of the residues involved would
require studies with a purified enzyme using
radiolabelled group-specific reagents followed
by sequence analysis.
The cross-linking technique has been applied to
intact ascites tumor cells to detect the intra-
cellular location of the enzyme.
Materials and Methods
Materials
Cross-linking reagents:
1) Dimethyl suberimidate dihydrochloride [= Sbi-
(OMe)2];
2) dimethyl 3,3'-dithiobis(propionimidate) dihydro-
chloride;
3) dimethyl A^A"-bis[2-(carboximido)ethyl]tartar-
imidate dihydrochloride;
4) sodium 2-(l-iminoethoxy)ethanesulphonate hydro-
chloride and
5) 3,3'-dithiobis[A/r-(propionyloxy)succinimide].
All five reagents were from Pierce, Rockford, IL,
U.S.A. Digitonin and Tes buffer (2-{[2-hydroxy-l,l-
bis(hydroxymethyl)ethyl) amino}ethanesulphonic
acid) were from Calbiochem, San Diego, Ca., U.S.A.
Glucose and sucrose were from May & Baker, Dagenham,
Essex, U.K. Triethanolamine and EDTA were from
Merck, Darmstadt, West Germany. All other reagents
were from Sigma, St. Louis, Mo., U.S.A.
Cells and enzyme preparations
A hyperdiploid strain of Ehrlich-Lettre ascites carcin-
oma (kindly supplied by Dr. J. Coll, Centro Especial
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Ramon y Cajal, Madrid) was grown in the abdominal
cavity of 2-month old male Swiss mice, by weekly
inoculation of 0.1 ml of ascitic fluid. Cells were
collected and mitochondria prepared as described by
Lazo and Sols^ 141 The mitochondrial fraction in these
conditions contained 80% of the total hexokinase
activity. The supernatant was centrifuged at 40000 χ g
for 30 min in a Sorvall RC-2B with an SS-34 rotor, and
the hexokinase in this cytosolic supernatant was con-
sidered as the soluble form of the enzyme.
The membrane-bound preparation behaved as a single
population of hexokinase II, characterized by the
kinetic parameters for the substrates and the lack of
any effect of Pj on the inhibition by glucose 6-phos-
phate^ J. This observation is confirmed by a different
groupl16L
Treatment of paniculate and soluble hexokinase
Mitochondria containing 7—10mg of protein were
suspended in 0.2 ml of O.lM triethanolamine, 75mM
NaCl, pH 8.5. To this suspension, 1.8 ml of the same
buffer containing 6 mg of imidoester, was added. The
solution of imidoester was prepared, taking great care
to prevent the pH from falling below pH 8.5; for this
2M NaOH was used. The final mitochondrial suspension
was incubated at 30 °C for 30 min in the presence or
absence of ligands, as indicated in the Results and
Discussion section. The reaction was stopped by adding
40 ml of cold 0.25M sucrose, 2mM EDTA, 2mM 2-
mercaptoethanol, lOmM triethanolamine, pH 7.4, and
the suspension was centrifuged at 10000 χ g for 15 min
to collect the mitochondria which were resuspended in
this buffer to a final concentration of 20% (w/v).
This procedure was common for all imidoesters used.
The drop in pH by the addition of buffer inactivates the
imidoesters. These mitochondrial suspensions were used
for enzymatic assays. When Reagent 3 was used, a parallel
experiment was done in which, after treatment of the
enzyme, the alcohol groups were oxidized by treatment
with 3mM sodium periodate during 5 min at 30 °C in
the above mentioned buffer, to break the cross-link.
The reaction was stopped by the addition of 100 ml of
cold buffer and centrifugation as above, otherwise,
periodate could lead to the inactivation of hexokinase
in approx. 45 min. Similarly, samples which have been
modified by bifunctional reagents containing disulphide
bridges (Reagent 2 or 5) were subsequently treated with
5mM dithioerythritol to cleave the cross-link^17!.
The soluble enzyme was treated as follows: 0.2 ml of
the cytosolic supernatant plus 1.8 ml of Sbi(OMe)2
solution was incubated under identical conditions to
the mitochondrial fraction, but the reaction was stopped
by carefully lowering the pH to 7.4 with O.lM HC1.
This solution was used for enzymatic determinations.
Cross-linking of cells
Ascites tumor cells were cross-linked with Sbi(OMe)o
following the general procedure of Aragon et 3ΐ.Ι18Γ
except that 30 mg of Sbi(OMe)2 per g of cells and 0.2%
digitonin was used.
Enzyme assays
Hexokinase was spectrophotometrically assayed using
l U of pyruvate kinase and l U lactate dehydrogenase,
3mM phosphewo/pyruvate, 0.2mM NADH, 5mM glucose
and 0.5mM Mg ATP in a mixture containing O.lM KC1,
5mM MgCl2, 5mM 2-mercaptoethanol, 50mM Tes
buffer, pH 7.4 in 1 ml of final volume, at 37 °C. The
activity was recorded in a 2400 Gilford spectrophoto-
meter. Lactate dehydrogenase and pyruvate kinase were
assayed as described by Aragon et alJ18!. Protein was
determined by the dye-binding method of Bradford^19!.
Results and Discussion
Treatment with dimethyl suberimidate
The cross-linking results with Sbi(OMe)2 are
summarized in the table. First of all it is important
to note that the soluble enzyme is completely
inactivated, while the membrane-bound form
retains its activity. This suggests that there is (a)
lysine group(s) not accessible to Sbi(OMe)2 in
the membrane-bound enzyme, that is required
for the catalytic process but is not in the active
site, since this site is still accessible in the mem-
brane-bound enzyme,. Probably the lysine res-
idue^) is required for the conformational changes
involved in the catalytic mechanism.
Whether this protection is due to its embedment
within the lipid environment, or is related to the
recently described hexokinase-binding protein in
liver mitochondrial20! has yet to be established.
Ascites tumor hexokinase binds equally well to
mitochondrial membrane of different sources I91.
The membrane-bound form retains its activity
when treated with Sbi(OMe)2 in the presence or
absence of glucose. However, modification in the
presence of glucose 6-phosphate fully inactivates
the enzyme, suggesting that (a) lysine residue(s)
required for the catalytic process becomes acces-
sible to Sbi(OMe)2. Sbi(OMe)2 does not solubilize
the enzyme, and the cross-linked mitochondrial
bound hexokinase could not be solubilized by
later addition of glucose 6-phosphate.
To test whether hexokinase was being solubilized
by glucose 6-phosphate t5·9! before the imido-
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Table. Effect of treatment wich imidoesters on the activity and inhibition by glucose 6-phosphate of hexokinase-II.
The treatment conditions are described in the Experimental section. For the soluble enzyme, the activity in this
fraction before treatment was taken as the reference value. For the intact cross-linked cells, the hexokinase activity
in a homogenate is the reference value. Results are means ± S.E.M. for n = 9 in the case of Sbi(OMe)2 and n = 6
with the other reagents, n.d. = not determined.
1) Mitochondria control
2) Mitochondria treated
with imidoesters
Imidoester
Additions
No additions
1 OmM glucose
ImM glucose 6-phosphate
lOmM W-acetylglucosamine
+ ImM glucose 6-phosphate
3) Soluble enzyme
4) Intact cross-linked cells
Activity
[%]
100 ±2
Apparent K j for
glucose 6-phosphate
[mM]
0.09 ± 0.01
Sbi(OMe)2
91 ±2
90 ±3
< 5*
40 ±2*
< 5*
100 ±5
0.50 ± 0.03*
2.00 ±0.10*
-
7 ± 0.20*
n.d.
0.50 ± 0.04*
Activity
[%]
Reagent 4
35 ± 3 *
91 ±2
17 ± 3*
15 ± 3 *
n.d.
n.d.
Reagent 3
96 ±3
63 ±2*
52 ±2*
52 ±3*
n.d.
n.d.
Reagent 3
cleaved
with 3mM
periodate
60 ± 4 *
120 ±4*
60 ±3*
63 ±4*
n.d.
n.d.
*P < 0.001
esters react, a control experiment was performed
to see the effect of glucose 6-phosphate under
the experimental conditions for the imidoester
reaction. The amount of hexokinase in the
supernatant, after the 10000 χ g spin, was less
than 10% and it could be sedimented at 40000 χ£,
suggesting that it is a particulate enzyme derived
from broken mitochondria under the harsh
conditions for imidoester treatment. A similar
effect was observed in the presence of reaction
buffer alone. This is what we expected if hexo-
kinase II behaves in a similar way to hexokinase I
under equivalent conditions of ionic strengh and
temperature I211. The alternative possibility, that
soluble, inactivated hexokinase could displace
the equilibrium can be ruled out by the above
information, as well as from the data with other
reagents (see table).
Therefore the inactivation is happening in the
membrane-bound form, but whether this lysine
residue(s) is the same as that exposed in the
soluble enzyme, cannot be determined in these
experiments. ./V-Acetyl-D-glucosamine, which
binds to the active site but does not induce a
conformational change, partly prevents the
inactivation achieved in the presence of glucose
6-phosphate.
When the membrane-bound enzyme was modified
in the presence or absence of glucose, the sen-
sitivity of the enzyme to the competitive (vs.
ATP) inhibition by glucose 6-phosphate is
decreased, particularly when treated in the
presence of glucose. This suggests that there is
a lysine group close to the allosteric site for
glucose 6-phosphate I22'23! involved in the
affinity for the effector, but not in the inhib-
itory mechanism since full inhibition can still
be achieved. The apparent Km for glucose and
MgATP were not affected in the modified en-
zyme.
All these data suggest the existence of at least
three different possible conformations in mem-
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brane-bound hexokinase II: one in the absence of
ligands, and the other two when complexed with
glucose or glucose 6-phosphate, respectively. This
is in agreement with the results from the brain
isoenzyme, where these ligands can induce dif-
ferent conformational changest3-6"8!.
Treatment with sodium 2-(l-iminoethoxy)-
ethanesulphonate hydrochloride
To test whether the effects described above were
a consequence of blocking lysine amino groups
or of cross-linking, the enzyme was treated with
the monofunctional imidoester 2-(l-iminoethoxy)-
ethanesulphonate (= Reagent 4, see table). Glucose
protects the enzyme from inactivation by this
reagent. Even in the absence of any addition,
Reagent 4 drops the activity much more than
does treatment with Sbi(OMe)2, suggesting that
the free and glucose-complexed forms of the
enzyme are different. In general the results
observed with bifunctional reagents, are a con-
sequence of both the blocking of amino groups
and of the strain imposed by the cross-linking.
An alternative explanation might be that
Sbi(OMe)2 reacts monofunctionally and the
differences are due to the different size of the
side chains of the reagents.
Treatment with other bifunctional reagents
Treatment with dimethyl 7\£JV-bis[2-(carboximido)·
ethyl]tartarimidate dihydrochloride (Reagent 3,
see table), a cleavable bis-imidoesterl28!, seems to
have no effect on enzyme activity when no ligand
is present. However, the addition of glucose or
glucose 6-phosphate decreases the enzyme activ-
ity by a factor of 2. After cross-linking, the
imidoester was cleaved with 3mM periodate,
converting it to monofunctional and liberating
the enzyme of the strain imposed by the cross-
link. The results obtained were similar except in
free and glucose-complexed enzyme. From the
data in both situations we can conclude that the
conformations of free, glucose-complexed and
glucose 6-phosphate-complexed enzyme are
different.
Other bifunctional reagents were tested: dimethyl
3,3 '-dithiobis(propionimidate) and 3,3 '-dithio-
bis[7V-(propionyloxy)succinimide]. Both contain
a cleavable disulphide bridge between the two
reactive groups. Both lead to full inactivation of
the enzyme irrespective of the ligands present.
After modification of the reagents with 5mM di-
thioerythritol (which results in reduction of the
disulphide bridge) no reactivation was detected.
Localization of hexokinase in intact cross-linked
cells
We used the fact that there is a very marked dif-
ference in lysine reactivity between the soluble
and membrane-bound hexokinase to investigate
the localization of the enzyme in cross-linked
cells. When intact cells were treated with Sbi(OMe)2,
the results were similar (see table), (concerning
activity and sensitivity to glucose 6-phosphate)
to that of membrane-bound hexokinase not
bound to any ligand. The possibility that this
difference was due to a permeability problem
of Sbi(OMe)2 was ruled out by measuring the
activity of other cytosolic enzymes in the treated
cells. Lactate dehydrogenase and pyruvate kinase
were both 80% inactivated. These activities were
localized inside the cross-linked cells, since after
centrifugation the activities were associated with
the pellet, ruling out the possibility of leaking
cells. These results suggest that most, if not all,
of hexokinase II in ascites tumor cells exists in
a membrane-bound form.
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